HUP0101600A2 - Eljárás N-metil-N-[(1S)-1-fenil-2-((3S)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilacetamid enantiomer tiszta formában való előállítására - Google Patents

Eljárás N-metil-N-[(1S)-1-fenil-2-((3S)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilacetamid enantiomer tiszta formában való előállítására

Info

Publication number
HUP0101600A2
HUP0101600A2 HU0101600A HUP0101600A HUP0101600A2 HU P0101600 A2 HUP0101600 A2 HU P0101600A2 HU 0101600 A HU0101600 A HU 0101600A HU P0101600 A HUP0101600 A HU P0101600A HU P0101600 A2 HUP0101600 A2 HU P0101600A2
Authority
HU
Hungary
Prior art keywords
phenyl
methyl
ethyl
hydroxypyrrolidine
free
Prior art date
Application number
HU0101600A
Other languages
English (en)
Inventor
Karl-August Ackermann
Andreas Bathe
Jens Budak
Rudolf Gottschlich
Bernd Helfert
Ingeborg Stein
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7865063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0101600(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0101600A2 publication Critical patent/HUP0101600A2/hu
Publication of HUP0101600A3 publication Critical patent/HUP0101600A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
    • C07B35/02—Reduction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

A találmány N-metil-N-[(1S)-1-fenil-2-((3S)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilacetamid vagy N-metil-N-[(1R)-1-fenil-2-((3R)-3-hidroxipirrolidin-1-il)etil]-2,2-difenil-acetamid új előállításieljárására és az előállításnál felhasználásra kerülő újintermedierekre, az N-metil-N-[(1S)-1-fenil-2-((3S)-3-hidroxipirrolidin-l-il)etán]-ra és N-metil-N-[(1R)-1-fenil-2-((3R)-3-hidroxipirrolidin-l-il)etán]-ra vonatkozik. Ó
HU0101600A 1998-04-20 1999-04-16 Method for producing enantiomer-free n-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidine-1-yl)ethyl]-2,2-diphenyl acetamide HUP0101600A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19817393 1998-04-20
DE19827633A DE19827633A1 (de) 1998-04-20 1998-06-20 Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
PCT/EP1999/002574 WO1999054298A1 (de) 1998-04-20 1999-04-16 Verfahren zur herstellung von enantiomerenreinem n-methyl- n-[(1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid

Publications (2)

Publication Number Publication Date
HUP0101600A2 true HUP0101600A2 (hu) 2001-09-28
HUP0101600A3 HUP0101600A3 (en) 2002-12-28

Family

ID=7865063

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101600A HUP0101600A3 (en) 1998-04-20 1999-04-16 Method for producing enantiomer-free n-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidine-1-yl)ethyl]-2,2-diphenyl acetamide

Country Status (28)

Country Link
US (1) US6344566B1 (hu)
EP (2) EP1073634B1 (hu)
JP (1) JP4688292B2 (hu)
KR (1) KR100649175B1 (hu)
CN (2) CN1846696A (hu)
AR (2) AR019080A1 (hu)
AT (2) ATE527999T1 (hu)
AU (2) AU761721B2 (hu)
BR (1) BR9909731A (hu)
CA (1) CA2329210C (hu)
CY (1) CY1112314T1 (hu)
CZ (1) CZ301121B6 (hu)
DE (2) DE19827633A1 (hu)
DK (2) DK1073634T3 (hu)
ES (2) ES2375384T3 (hu)
HK (1) HK1039111A1 (hu)
HU (1) HUP0101600A3 (hu)
MY (1) MY120471A (hu)
NO (1) NO317984B1 (hu)
PL (1) PL206969B1 (hu)
PT (1) PT1607090E (hu)
RU (1) RU2298549C2 (hu)
SI (2) SI1607090T1 (hu)
SK (2) SK286442B6 (hu)
TW (1) TWI249524B (hu)
UA (1) UA73472C2 (hu)
WO (1) WO1999054298A1 (hu)
ZA (1) ZA200006689B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
CA2544245A1 (en) * 2003-10-30 2005-05-26 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
US20070160559A1 (en) * 2006-01-12 2007-07-12 Roszell James A Skin disinfectant composition and methods for using
CN101677997B (zh) 2007-03-30 2012-05-09 泰奥加制药公司 用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
CN103664727A (zh) * 2013-12-19 2014-03-26 无锡万全医药技术有限公司 一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
CN103772257A (zh) * 2013-12-31 2014-05-07 无锡万全医药技术有限公司 一种制备2-((3s)-3-羟基吡咯烷-1-基)-(1s)-1-苯乙基氨基甲酸酯的方法
EP3277274A4 (en) 2015-04-01 2018-12-05 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
CN112574068A (zh) * 2020-11-17 2021-03-30 万华化学（宁波）有限公司 一种低色号高稳定性碳化二亚胺改性异氰酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
DE4425071C2 (de) * 1994-07-15 1996-08-29 Degussa Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit
DE19523502A1 (de) * 1995-06-28 1997-01-02 Merck Patent Gmbh Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE19531464A1 (de) * 1995-08-26 1997-02-27 Merck Patent Gmbh N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid
WO1998003491A1 (en) * 1996-07-24 1998-01-29 Warner-Lambert Company Diphenyl-cyclopropenes as selective k-agonists
DE19647538A1 (de) * 1996-11-16 1998-05-20 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[1-phenyl-2-(-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Also Published As

Publication number Publication date
AU2003248428B2 (en) 2005-10-20
EP1607090A1 (de) 2005-12-21
UA73472C2 (en) 2005-08-15
KR100649175B1 (ko) 2006-11-24
CA2329210C (en) 2008-03-04
SI1607090T1 (sl) 2012-01-31
NO20005259D0 (no) 2000-10-19
JP2002512223A (ja) 2002-04-23
DK1607090T3 (da) 2012-01-30
JP4688292B2 (ja) 2011-05-25
TWI249524B (en) 2006-02-21
PL343556A1 (en) 2001-08-27
DE19827633A1 (de) 1999-10-21
ATE527999T1 (de) 2011-10-15
CN1846696A (zh) 2006-10-18
NO20005259L (no) 2000-10-19
AR066455A2 (es) 2009-08-19
PL206969B1 (pl) 2010-10-29
AU761721B2 (en) 2003-06-05
EP1607090B1 (de) 2011-10-12
WO1999054298A1 (de) 1999-10-28
HUP0101600A3 (en) 2002-12-28
CY1112314T1 (el) 2015-12-09
ATE303361T1 (de) 2005-09-15
EP1073634A1 (de) 2001-02-07
EP1073634B1 (de) 2005-08-31
PT1607090E (pt) 2012-01-10
ES2375384T3 (es) 2012-02-29
DK1073634T3 (da) 2006-01-09
RU2298549C2 (ru) 2007-05-10
ZA200006689B (en) 2002-02-18
CN1297435A (zh) 2001-05-30
AU4031199A (en) 1999-11-08
SI1073634T1 (sl) 2006-02-28
CN1310884C (zh) 2007-04-18
CZ301121B6 (cs) 2009-11-11
NO317984B1 (no) 2005-01-17
MY120471A (en) 2005-10-31
SK288016B6 (sk) 2012-11-05
BR9909731A (pt) 2000-12-19
CZ20003860A3 (cs) 2001-01-17
ES2251194T3 (es) 2006-04-16
SK286442B6 (sk) 2008-10-07
KR20010042750A (ko) 2001-05-25
AR019080A1 (es) 2001-12-26
AU2003248428A1 (en) 2003-11-06
HK1039111A1 (en) 2002-04-12
US6344566B1 (en) 2002-02-05
SK15572000A3 (sk) 2001-05-10
CA2329210A1 (en) 1999-10-28
DE59912502D1 (de) 2005-10-06

Similar Documents

Publication Publication Date Title
YU37696A (sh) Postupak optičkog prečišćavanja jedinjenja
EA200300187A1 (ru) Способ получения n-арилантраниловых кислот и их производных
ATE234092T1 (de) 2-alkylpyrrolidine
GT199800197AA (es) Proceso para la sintesis de 1,3-dioles
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
ATE201203T1 (de) Chirale methylphenyloxazolidinone
HUP0101600A2 (hu) Eljárás N-metil-N-[(1S)-1-fenil-2-((3S)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilacetamid enantiomer tiszta formában való előállítására
BRPI0411471A (pt) método para produzir um não-trançado fibroso e não-trançado fibroso
PT879228E (pt) Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao
GB0216001D0 (en) Process and composition
BR0107847A (pt) Processo para purificar ácido (met) acrìlico por cristalização
AU2003301857A1 (en) New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
BR0207693B1 (pt) processo e aparelho para produzir continuamente uma composição elastomérica.
BR0212227A (pt) Processo para desbaste de frutas
NO963526D0 (no) N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etylÅ-2,2-difenylacetamid
WO2004046293A3 (en) Amphoteric fluorescent whitening agents
PL377441A1 (pl) Sposób wytwarzania stereoizomeru glikopironiowego o konfiguracji R,R (lub S,S)
RS83104A (en) Process to prepare eplerenone
IT1298349B1 (it) Processo per la produzione di 1 - (3-trifluorometil) fenil-propan- 2-one intermedio nella sintesi della fenfluramina
ATE381920T1 (de) Retinolderivate und verfahren zu deren herstellung
AR039152A1 (es) Lasofoxifeno racemico purificado y d-tartrato de lasofoxifeno purificado y un metodo para la purificacion efectiva del lasofoxifeno racemico
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
DE69425149D1 (de) Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
AU2003244235A1 (en) Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: TIOGA PHARMACEUTICALS, INC., US

Free format text: FORMER OWNER(S): MERCK PATENT GMBH, DE

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished